By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi (France) 

Parent Company
174/180 Avenue de France
Paris  Cedex  75013  France
Phone: 33-1-53-77-4000 Fax:



Company News
Sanofi (SNY) Announces Launch Of Authorized Generic Version Of Arava (Leflunomide) Tablets 10/1/2015 7:33:42 AM
Sanofi (SNY) New Drug Application For Lixisenatide Accepted For Review By FDA 9/29/2015 6:18:52 AM
Sanofi (SNY), Eli Lilly (LLY) Reach Patent Deal on Lantus SoloSTAR 9/28/2015 8:26:43 AM
As Spinoff Rumors Spin, Sanofi (SNY)’s Cholesterol Drug Praluent Gets Approval in Europe 9/28/2015 7:56:51 AM
Sanofi (SNY) CEO Mulls Company Restructuring, Possible Bio-Surgery and Renal Unit Sales 9/25/2015 5:51:36 AM
Rumors Spreading that Sanofi (SNY), Pfizer (PFE), Abbott (ABT) and Others Might Buy Mexican Generics Company Rimsa 9/21/2015 6:38:17 AM
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says 9/16/2015 10:20:09 AM
Peptidream Announces Peptide Discovery Collaboration Agreement With Sanofi (SNY) 9/14/2015 12:42:30 PM
Sanofi (SNY) Plans LixiLan Filings After Meeting Phase III Primary Endpoint 9/14/2015 6:33:05 AM
Sanofi (SNY) Eyes Major Expansion at UK Site 9/4/2015 6:41:35 AM